View Item 

Show simple item record

Meta‐analysis for Surrogacy: Accelerated Failure Time Models and Semicompeting Risks Modeling

dc.contributor.authorGhosh, Debashisen_US
dc.contributor.authorTaylor, Jeremy M. G.en_US
dc.contributor.authorSargent, Daniel J.en_US
dc.date.accessioned2012-04-04T18:42:20Z
dc.date.available2013-05-01T17:24:43Zen_US
dc.date.issued2012-03en_US
dc.identifier.citationGhosh, Debashis; Taylor, Jeremy M. G.; Sargent, Daniel J. (2012). "Meta‐analysis for Surrogacy: Accelerated Failure Time Models and Semicompeting Risks Modeling." Biometrics 68(1). <http://hdl.handle.net/2027.42/90527>en_US
dc.identifier.issn0006-341Xen_US
dc.identifier.issn1541-0420en_US
dc.identifier.urihttps://hdl.handle.net/2027.42/90527
dc.publisherWiley Periodicals, Inc.en_US
dc.publisherBlackwell Publishing Incen_US
dc.subject.otherCopulaen_US
dc.subject.otherLatent Factoren_US
dc.subject.otherLinear Regressionen_US
dc.subject.otherMultivariate Failure Time Dataen_US
dc.subject.otherSingular Value Decompositionen_US
dc.subject.otherDependent Censoringen_US
dc.titleMeta‐analysis for Surrogacy: Accelerated Failure Time Models and Semicompeting Risks Modelingen_US
dc.typeArticleen_US
dc.rights.robotsIndexNoFollowen_US
dc.subject.hlbsecondlevelMathematicsen_US
dc.subject.hlbtoplevelScienceen_US
dc.description.peerreviewedPeer Revieweden_US
dc.contributor.affiliationumDepartment of Biostatistics, University of Michigan, Ann Arbor, Michigan 48103, U.S.A.en_US
dc.contributor.affiliationotherDepartment of Health Sciences Research, Mayo Clinic, Rochester, Minnesota 55905, U.S.A.en_US
dc.contributor.affiliationotherDepartments of Statistics and Public Health Sciences, The Pennsylvania State University, University Park, Pennsylvania 16802, U.S.A.en_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/90527/1/j.1541-0420.2011.01633.x.pdf
dc.identifier.doi10.1111/j.1541-0420.2011.01633.xen_US
dc.identifier.sourceBiometricsen_US
dc.identifier.citedreferencePrentice, R. L., Kalbfleisch, J. D., Peterson, A. V., Flournoy, N., Farewell, V. T., and Breslow, N. E. ( 1978 ). The analysis of failure times in the presence of competing risks. Biometrics 34, 541 – 554.en_US
dc.identifier.citedreferenceClayton, D. G. ( 1978 ). A model for association in bivariate life tables and its application in epidemiological studies of familial tendency in chronic disease incidence. Biometrika 65, 141 – 151.en_US
dc.identifier.citedreferenceDaniels, M. J. and Hughes, M. D. ( 1997 ). Meta‐analysis for the evaluation of potential surrogate markers. Statistics in Medicine 16, 1515 – 1527.en_US
dc.identifier.citedreferenceFine, J. P., Jiang, H., and Chappell, R. ( 2001 ). On semi‐competing risks data. Biometrika 88, 907 – 919.en_US
dc.identifier.citedreferenceFreedman, L. S., Graubard, B. I., and Schatzkin, A. ( 1992 ). Statistical validation of intermediate endpoints for chronic disease. Statistics in Medicine 11, 167 – 178.en_US
dc.identifier.citedreferenceGail, M. H., Pfeiffer, R., van Houwelingen, H. C., and Carroll, R. J. ( 2000 ). On meta‐analytic assessment of surrogate outcomes. Biostatistics 1, 231 – 246.en_US
dc.identifier.citedreferenceGhosh, D. ( 2006 ). Semiparametric inferences for the association parameter with semi‐competing risks data. Statistics in Medicine 25, 2059 – 2070.en_US
dc.identifier.citedreferenceGhosh, D. ( 2008 ). Semiparametric inference for surrogate endpoints with bivariate censored data. Biometrics 64, 149 – 156.en_US
dc.identifier.citedreferenceGhosh, D. ( 2009 ). On assessing surrogacy in a single trial setting using a semi‐competing risks paradigm. Biometrics 65, 521 – 529.en_US
dc.identifier.citedreferenceLi, Y. and Taylor, J. M. ( 2010 ). Predicting treatment effects using biomarker data in a meta‐analysis of clinical trials. Statistics in Medicine 29, 1875 – 1889.PubMed PMID: 20680981.en_US
dc.identifier.citedreferenceLin, D. Y., Robins, J. M., and Wei, L. J. ( 1996 ). Comparing two failure time distributions in the presence of dependent censoring. Biometrika 83, 381 – 393.en_US
dc.identifier.citedreferenceLouis, T. A. ( 1981 ). Nonparametric analysis of an accelerated failure time model. Biometrika 68, 381 – 390.en_US
dc.identifier.citedreferenceNelsen, R. ( 1999 ). An Introduction to Copulas. New York: Springer.en_US
dc.identifier.citedreferenceOakes, D. ( 1982 ). A model for association in bivariate survival data. Journal of the Royal Statistical Society, Series B 44, 414 – 422.en_US
dc.identifier.citedreferenceOakes, D. ( 1986 ). Semiparametric inference in a model for association in bivariate survival data. Biometrika 73, 353 – 361.en_US
dc.identifier.citedreferenceOakes, D. ( 1989 ). Bivariate survival models induced by frailties. Journal of the American Statistical Association 84, 487 – 493.en_US
dc.identifier.citedreferencePrentice, R. L. ( 1989 ). Surrogate endpoints in clinical trials: Definition and operational criteria. Statistics in Medicine 8, 431 – 440.en_US
dc.identifier.citedreferenceSargent, D. J., Wieand, H. S., Haller, D. G., Gray, R., Benedetti, J. K., Buyse, M., Labianca, R., Seitz, J. F., O'Callaghan, J., Francini, G., Grothey, A., O'Connell, M., et al. ( 2005 ). Disease‐free survival versus overall survival as a primary end point for adjuvant colon cancer studies: Individual patient data from 20,989 patients on 18 randomized clinical trials. Journal of Clinical Oncology 23, 8664 – 8670.en_US
dc.identifier.citedreferenceShih, J. and Louis, T. A. ( 1995 ). Inference on the association parameter in copula models for bivariate survival data. Biometrics 51, 1384 – 1399.en_US
dc.identifier.citedreferenceTipping, M. and Bishop, C. M. ( 1999 ). Probabilistic principal component analysis. Journal of the Royal Statistical Society, Series B 61, 611 – 622.en_US
dc.identifier.citedreferencevan der Vaart, A. ( 2000 ). Asymptotic Statistics. Cambridge: Cambridge University Press.en_US
dc.identifier.citedreferenceWang, Y. and Taylor, J. M. ( 2002 ). A measure of the proportion of treatment effect explained by a surrogate marker. Biometrics 58, 803 – 812.en_US
dc.identifier.citedreferenceWang, W. and Wells, M. T. ( 2000 ). Model selection and semi‐parametric inference for bivariate censored data (with discussion). Journal of American Statistical Association 95, 62 – 76.en_US
dc.identifier.citedreferenceYing, Z. ( 1993 ). A large‐sample study of rank estimation for censored regression data. The Annals of Statistics 21, 76 – 99.en_US
dc.identifier.citedreferenceZeng, D. and Lin, D. Y. ( 2008 ). Efficient resampling methods for nonsmooth estimating functions. Biostatistics 9, 355 – 363.en_US
dc.identifier.citedreferenceBurzykowski, T., Molenberghs, G., Buyse, M., Geys, H., and Renard, D. ( 2001 ). Validation of surrogate endpoints in multiple randomized clinical trials with failure‐time endpoints. Applied Statistics 50, 405 – 422.en_US
dc.identifier.citedreferenceBurzykowski, T., Molenberghs, G., and Buyse, M. ( 2005 ). The Evaluation of Surrogate Endpoints. New York: Springer‐Verlag.en_US
dc.identifier.citedreferenceBuyse, M. and Molenberghs, G. ( 1998 ). Criteria for the validation of surrogate endpoints in randomized experiments. Biometrics 54, 1014 – 1029.en_US
dc.identifier.citedreferenceBuyse, M., Molenberghs, G., Burzykowski, T., Renard, D., and Geys, H. ( 2000 ). The validation of surrogate endpoints in meta‐analysis of randomized experiments. Biostatistics 1, 49 – 67.en_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
j.1541-0420.2011.01633.x.pdf
Size:
759.0KB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.